Level 2

Director/PDMR Shareholding

By LSE RNS

Date: Wednesday 25 Feb 2026

Director/PDMR Shareholding







RNS Number : 4215U
GSK PLC
25 February 2026




GSK plc (the 'Company')


Transaction notification





























































































1.



Details of PDMR/person closely associated with them ('PCA')



a)



Name



Diana Conrad



b)



Position/status



Chief People Officer



c)



Initial notification/


amendment



Initial notification



2.



Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor



a)



Name



GSK plc



b)



LEI



5493000HZTVUYLO1D793



3.



Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transaction(s) has been conducted



a)



Description of the financial instrument



American Depositary Shares ('ADS')


ISIN: US37733W2044




b)



Nature of the transaction



Acquisition of ADS under GSK pension plan



c)



Price(s) and volume(s)






Price(s)



Volume(s)









CAD 82.8205



11.163


















d)



Aggregated information





N/A (single transaction)



Aggregated volume Price






e)



Date of the transaction



2026-02-13



f)



Place of the transaction




New York Stock Exchange (XNYS)









About GSK


GSK is a global biopharma company with a purpose to unite science, technology, and talent to get ahead of disease together. Find out more at www.gsk.com.



Registered in England & Wales:


No. 3888792



Registered Office:


79 New Oxford Street


London


WC1A 1DG










This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
DSHSEFFMIEMSEIE

« Go back to news channel

..

Email this article to a friend

or share it with one of these popular networks:


Top of Page